Triumeq Tablet, Film Coated
Product Images NDC 49702-231

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Triumeq (NDC 49702-231). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viiv Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ziagen Chem Structure (Triumeq Spl Graphic 01)

Chemical structure diagram depicting a component of the active ingredients in Triumeq PD, showing a complex bicyclic heterocyclic ring system with attached amino and hydroxymethyl groups and a cyclopropyl substituent, along with a sulfate counter ion indicated (-H2SO4).*

FDA Label Image

Dolutegravir Chemical Structure (Triumeq Spl Graphic 02)

Chemical structure diagram of the active ingredient dolutegravir sodium in the Triumeq PD kit. The diagram shows the molecular formula with labeled atoms and bonds.*

FDA Label Image

Epivir Chem Struc (Triumeq Spl Graphic 03)

Chemical structure of abacavir sulfate, an active ingredient in Triumeq PD, showing its molecular framework with nitrogen, oxygen, sulfur, and hydrogen atoms in a heterocyclic arrangement.*

FDA Label Image

Triumeq 30 Count Carton (Triumeq Spl Graphic 04)

Illustration showing a bottle and a dosing cup side by side. The cup is labeled with volume markings from 15 mL to 40 mL, indicating graduated measurement levels for liquid dispensing.*

FDA Label Image

Triumeq Spl Graphic 05

An instructional diagram titled 'Water Volume Guide' showing tablet counts and corresponding water volumes. The table indicates 4 tablets with no volume specified, 5 tablets require 20 mL of water, and 6 tablets are listed without a volume. Next to the table is a clear measuring cup marked in milliliters from 15 mL to 40 mL, with water being poured into the cup.*

FDA Label Image

Triumeq Spl Graphic 06

An instructional illustration showing two steps: first, a hand dropping a tablet into a medicine cup marked with volume measurements (15 to 40 mL); second, another hand swirling the cup with an arrow indicating a 1 to 2 minute swirling motion.*

FDA Label Image

Triumeq Spl Graphic 07

An instructional illustration depicting a hand administering oral medication to a child. The child is shown drinking from a small cup held by the hand, demonstrating how to give the medication orally.*

FDA Label Image

Triumeq Spl Graphic 08

An instructional illustration showing two hands holding a triangular tea bag under running water, with water droplets splashing around it. The image suggests washing or rinsing the tea bag before use.*

FDA Label Image

Triumeq Spl Graphic 09

Triumeq PD kit label showing film-coated tablets containing abacavir sulfate 600 mg, dolutegravir sodium 50 mg, and lamivudine 300 mg per tablet. The label includes dosage form as tablets, a 30-tablet count, and the ViiV Healthcare Company as the manufacturer. Storage and dispensing information are also provided.*

FDA Label Image

Triumeq Spl Graphic 10

Triumeq PD tablets for oral suspension packaging label showing the active ingredients abacavir, dolutegravir, and lamivudine with strengths of 60 mg, 5 mg, and 30 mg respectively. The label notes the product is prescription only and includes a content list of 90 tablets, a dosing cup, prescribing information, medication guide, and instructions for use. Labeled by ViiV Healthcare Company.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.